Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cory Adam Perugino, D.O.

Co-Author

This page shows the publications co-authored by Cory Perugino and Naoki Kaneko.
Connection Strength

1.138
  1. Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19. Clin Immunol. 2022 Mar 29; 237:108991.
    View in: PubMed
    Score: 0.249
  2. Expansion of Cytotoxic CD4+ T cells in the lungs in severe COVID-19. medRxiv. 2021 Mar 26.
    View in: PubMed
    Score: 0.232
  3. CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease. J Allergy Clin Immunol. 2021 01; 147(1):368-382.
    View in: PubMed
    Score: 0.219
  4. Immune mechanisms of fibrosis and inflammation in IgG4-related disease. Curr Opin Rheumatol. 2020 03; 32(2):146-151.
    View in: PubMed
    Score: 0.215
  5. Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease. Rheumatology (Oxford). 2021 10 02; 60(10):4929-4941.
    View in: PubMed
    Score: 0.060
  6. CD4+CTLs in Fibrosing Mediastinitis Linked to Histoplasma capsulatum. J Immunol. 2021 02 01; 206(3):524-530.
    View in: PubMed
    Score: 0.057
  7. Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis. J Clin Invest. 2020 05 01; 130(5):2451-2464.
    View in: PubMed
    Score: 0.054
  8. B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. J Allergy Clin Immunol. 2020 03; 145(3):968-981.e14.
    View in: PubMed
    Score: 0.052
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.